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Highly purified ceruloplasmin (CP) was isolated from human bile using affinity chromatography. Bilhry CP is represented bytwo molecular species. 
One of those is identical to oxidase CP from normal human serum while the other is analogous to oxidase-lacking CP specific for the serum of 
the carriers of Wilson’s mutation with respect to immunological specificity, electrophoretical mobility and molecular mass of the large fragments 
from spontaneous protcolysis, 
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1. INTRODUCTION 
A Cl?-like protein has been detected recently in 
human bile [l]. Since its content in the bile correlated 
directly with the amount of copper consumed with the 
food, a suggestion was made that this protein is in- 
volved in the copper excretion via bile and in the preven- 
tion of copper re-absorption from the intestine. This 
protein was not detected immunologically in the bile of 
patients with Wilson’s disease’ [l]. On the other hand, 
a protein immunologically related to biliary CP was 
found in the sera of homo- and heterozygous carriers 
of Wilson’s disease gene. This oxidase-negative species 
of CP appeared to be specific for the carriers of Wilson’s 
mutation and, therefore, was referred to as Wilsonian 
CP [2]. 
Affinity sorbent for CP was synthesized using cyanogen bromide. 
activated Sepharose 48 [3]. Hcxamethylene diaminc and succinic an- 
hydride served as spacers, while pphenylene diamine was the CP- 
specific ligand. 
Isolation of homogeneous Wilsonian CP and preparation of mono- 
specific antibodies against his protein were described elsewhere [2.4]. 
Electrophoresis under native and denaturing conditions, immune. 
elcctrophoresis and immunablotting were carried out according to the 
routine procedures [5-S]. 
3. RESULTS AND DISCUSSION 
Hence, purification of CP from normal human bile 
and its comparison with the serum counterpart from 
HLD patients may contribute to a better understanding 
of both the physiological role of CR in copper metabo- 
lism and the molecular mechanism of its inherited efect 
in Wilson’s disease. 
2. MATERIALS AND METHODS 
The bile obtainbd via biliary duct drainage in patients with 
gallstones after cholecystectomy served its the source of biliary CP. 
The commercial CP preparation was obtained from Pasteur Institute 
of Epidemiology and Microbiology, St. Pctcrsburg. 
The afinity chromatography on p-phenylene 
diamine-Sepharose 4Ballowed the single-stage isolation 
of both normal and Wilsonian CPs from human sera in 
a high yield [4]. However, our attempts to obtain CP 
preparations from the whole bile using this single-stage 
method failed. That was due to high affinity of bile 
pigments to amino groups of the sorbent, which inter- 
fered with CP sorption. The bulk of bile pigments was 
removed by precipitation of proteins (including CP) in 
25% PEG 6000 for 12 h at 4OC (the extent of CP pre- 
cipitation was controlled using rocket immuno-electro- 
phoresis). Nevertheless, a minor admixture of of pro- 
tein-bound bile pigments left after PEG precipitation 
prevented the direct isolation of CP from this material 
using affinity chromatography. 
Abbreviutiorw: CP, cerdoplasmin; HLD, hcpatolenticular degenera- 
tion (Wilson’s disease); PAAG, polyacrylamide gel; SDS, sodium do- 
decyl sulphate; PEG, polyethylcnc glycol. 
The effective removal of bile pigments was achieved 
by 2S% PEG 6000 precipitation followed by chromato- 
graphy of precipitated material on Sephadex G-100. 
Fig. 1 shows that biliary proteins were eluted from Se- 
phadex G-100 in three pe3b.s. The eluilcn volume of the 
first peak (high molecular mass proreinsj was the same 
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Fig. 1. Gel-filtration of biliary proteins precipitated with PEG. 50 ml of bile were mixed with 15 g of PEG 6000. The precipitate was collected by 
centrifugation, washed with 25% PEG and dissolved in 10 ml of 0.05 M sodium acetate buffer, pH 5.5. The suspension was cleared by centrifugation 
and applied to Sephadex G-100 column (2 x 50 cm), and equilibrated with the same buffer. Fraction volume was 7 ml. (A) Elution profile. (B) 
Rocket immunoelectrophorcsis of the starling material (SM), and of the fractions of eluate (G-10). Immunoelectrophoresis was carried out in 1% 
agarose gels containing 0.1 mg/ml IgG from immune sera. (a) Antibodies to normal oxidasc-positive CP, o-dianizidine staining. (b) Monospecific 
antibodies to Wilsonian CP, Coumassie R-250 slaining. 
as that of purified preparation of human serum CP used 
as a marker to calibrate the column. 
The immunological estimations howed that both 
normal CP and Wilsonian CP were eluted in the first 
peak (see Fig. 1B). The CP-containing fractions of this 
peak were pooled, re-precipitated by 25% PEG, pelleted 
in a centrifuge, dissolved and fractionated by ion ex- 
change chromatography on a DEAE-Sepharose column 
2A 
b 
6 
10 20 fraction5 
Fig. 2. Ion-exchange chromalography of CP-containing fraction of biliary proteins obtained upon gel-filtration. CPmcontaining fractions eluted 
from Sephadex G-100 column were pooled and applied to a SO-ml DEAE-Sepharosc column equilibrated with 0.05 M sodium acetate buffer, pH 
5.5. FracLion volume was 7 ml. (A) ELion profile. The First peak (fractions 6-10) corresponds to unbound pro&s (elutcd with the equilibrating 
buffer). The arrow indicates the switch to the eluling buffer (0.3 M sodium chloride, 0.05 M sodium acetate buffer, pii 5,5), (3) Ro-ckel 
immunoelectrophoresis of the eluate fractions (8, l9,21 and 22) in 1% agarose gel containing antibodies to oxidase CP and monospecific antibodies 
to Wilsonian CP (100 pug/ml of each). The gel was stained with o-dianizidine and then with Coomassie R-250. o-Dianizidine stained only internal 
rockets. 
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Fig. 3. Non-denaturing PAAG cl~trophoresis~immunoblo~ting of 
biliary CP. Purified biliary CP was fractionated by electrophoresis in 
7.5% PAAG, pH 8.8, under non-denaturing conditions. The protein 
was transferred onto nitrocellulose fiber by clectraclution and 
analyzed by immunoblotting with antibodies to normal CP (1) and 
monospecific antibodies to Wilsonian CP (2). The bands containing 
bound antibodies were detected with [lz’I]protein A, followed by ra- 
dioautography. The arrow indicates the position of the band of CP 
isolated from donor serum. 
which, as had been shown earlier [4], retained normal 
CP, but did not adsorb Wilsonian CP. The immunologi- 
cal assay of eluate fractions showed that biliary CP was 
fully retained by DEAE-Sepharose (Fig. 2). 
Subsequent affinity chromatography was carried out 
using the CP-specific sorbent. The CP-containing frac- 
tions elutcd from ion exchange column were pooled, 
dialyzed against 0.05 M sodium acetate buffer, pH 5.5, 
and applied to the column with the affinity sorbent 
equilibrated with the same buffer. After the column was 
washed with equilibrating buffer, the retained proteins 
were eluted with 0.3 M sodium chloride. As was evident 
from immunoelectrophoretic data (not shown), the pro- 
tein fractions washed out with equilibrating buffer con- 
tained no immunoreactive CP; both molecular forms of 
biliary CP having been retained on the sorbent and 
eluted with 0.3 M sodium chloride. 
Electrophoresis of these fractions under non-denatur- 
ing conditions howed that CP migrated as two bands 
stained with Coomassie R-250. One of those could be 
stained also with o-dianizidine, a specific chromogenic 
substrate for CP oxidase activity, and corresponded to 
the normal serum CP in its migration rate. This fraction 
was recognized by antibodies to normal CP when im- 
munoblotting was applied (Fig. 3). The other band was 
not stained with o-dianizidine and interacted only with 
monospecific antibodies to Wilsonian CP. 
: 
Fig. 4. Denaturing el-electrophorcsi! I ( ,f Wilsonian CP from HLD . . serum and of biliary CP which interacts wnn monospecific antibodies 
to Wilsonian CP. CP preparations from HLD serum (I) and from 
human bile (2) were subjected toelestrophoresis under nondenaturing 
conditions in 7.5% PAAG. Gel strips corresponding to the location 
of oxidase-negative CP species were cut out, homopnized and rc- 
electrophorcsed in denaturing 7.5% PAAG-SDS. according to 
Laemmli [7l, Protein bands were lrctrocluted onto nirrocellulose filter 
and incubated with monaspecific nntibodies against Wilsonian CP. 
The bands containing bound antibodies wcrc detetied, using pzr- 
oxidase-conjugated protein A, The intensity of proxidase-stained 
bands was recorded in laser densitometer (Biomcd. International, 
USA); Arrows indicate the positions of molecular mass markers: 
bovine serum albumin (BSA) = 66 kDa; ovnlbumin (OVA) = 45 kDa; 
carbonic anhydrase (CA) = 29 kDa. 
Two similar protein bands were also detected earlier, 
when CP preparations from I-ILD sera were frac- 
tionated electrophoretically under non-denaturing con- 
ditions [2,4]. One (fast) band was stained with o-diani- 
zidine and had the mobility of CP isolated from healthy 
donor blood. The other (slow) band, lacked oxidase 
activity, but interacted with antibodies to CP. Isolation 
of this CP (Wilsonian CP), its characterization and 
preparation of monospecific antibodies have been de- 
scribed in our previous paper [?I. 
Biliary @I; recognized by the iatter antibodies and 
oxidase-negative CP isolated from the serum of HLD 
patients were compared using PAAG-SDS electropho- 
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r&s. It was shown (Fig, 4) that the biliary CP interact- 
ing with monospecific antibodies against Wilsonian CP 
was represented by two polypeptides (80 and 40 kDa) 
identical in their molecular mass to those of Wilsonian 
CP. 
These data allow one to conclude that normal human 
bile contains at least two molecular forms of CP. With 
respect o their oxidase activity, antigenic properties, 
electrophoretic mobility, one of them is identical to the 
normal serum CP, while the other is similar to Wil- 
sonian CP. 
Now, the question arises how these CP forms appear 
in the bile. It has been shown earlier that the membrane 
fraction of hepatocytes from norma.: human liver con- 
tains polypeptides related antigenically to Wilsonian CP 
191. Resides, we showed in the model experiments that 
rat liver cells synthesize a molecular form of CP which 
is not secreted into the blood stream [lo]. These facts 
alongside with the data on the role of liver lysosomes 
in the copper excretion [l l] suggest hat biliary CP 
species devoid of oxidase activity is involved in the bind- 
ing of copper taken up by hepatocytes from the blood. 
The copper bound to this protein is likely to be either 
m-incorporated into a newly synthesized secretory CP, 
or as a part of the oxidase-negative CP is excreted via 
lysosomes into the bile. 
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